Search

Continued from Page 1 2022-23. 'Patients in Surrey are likely to receive the procedure in less than 90 minutes, while those in Bedford, Luton, and Milton Keynes must wait around [...]

New research is shedding light on the relationship between migraines and cardiovascular and stroke-related outcomes. A study found that individuals with migraine, particularly men with aura, have an increased risk of major adverse cerebrovascular and cardiovascular events (MACE). The study also revealed that certain risk factors, such as atrial fibrillation, hypertension, and hyperlipidemia, further increase the risk of MACE. Additionally, the research showed that there is an interaction between male sex and aura, as well as between aura and hypertension and tobacco use. The findings highlight the need for further investigation into the specific factors that contribute to MACE risk in migraine patients. [Extracted from the article]

The ABYSS trial examined the impact of interrupting beta-blocker therapy in patients post-myocardial infarction (MI) and found that it was not noninferior to continuing the drugs. The study's primary endpoint included death, MI, stroke, or hospitalization for any cardiovascular reason, with higher rates of cardiovascular hospitalization driving the results. Despite some conclusions suggesting the need to continue beta-blockers, the author argues that the results align with previous studies and support the possibility of stopping medication post-MI. The study highlights the importance of careful trial design and interpretation in medical research. [Extracted from the article]

Lake Forest: Gravity Medical Technology, a leading innovator in stroke treatment technology, announces the launch of the GRASSROOT Trial in India. The trial aims to enroll 60 patients to study [...]

A Danish study involving 1.7 million women found that those who used levonorgestrel-releasing intrauterine devices (LG-IUDs) had a 22% lower risk of ischemic stroke compared to those who did not use hormonal contraception. The study also showed no increased risk for intracerebral hemorrhage for those using the IUDs. Previous research had suggested that progestin-only options, including LG-IUDs, are not associated with an elevated risk of stroke and may even lower the risk. However, the researchers cautioned that further research is needed to confirm these findings. [Extracted from the article]

A new study has found that adults over the age of 50 who experience chronic loneliness have a 56% increased risk of stroke. The study, which examined changes in loneliness over time, found that the increased risk did not apply to individuals who reported situational loneliness. Loneliness has been linked to cardiovascular disease in previous research, but this study is one of the first to examine the association between loneliness and stroke risk. The researchers speculate that physiological factors, behavioral factors, and psychosocial issues may contribute to the association. Clinicians are encouraged to routinely assess loneliness and provide appropriate care to address the associated health risks. [Extracted from the article]

A subanalysis of the NOAH-AFNET 6 trial has shown that oral anticoagulation with edoxaban does not reduce the risk of a second stroke in patients who have already had a stroke. The study involved 253 patients with device-detected atrial fibrillation (AF) who had previously experienced a stroke or transient ischemic attack (TIA). The results showed that anticoagulation with edoxaban did not significantly impact stroke rates or other cardiovascular outcomes, but did increase the risk of major bleeding. These findings suggest a need for better markers to evaluate stroke risk and highlight the complexity of determining the appropriate anticoagulation treatment for patients with stroke. [Extracted from the article]

2024 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Current study results on Central Nervous System Diseases and Conditions - Cerebral Infarction have been [...]

2024 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at World Disease Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

2024 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- Investigators publish new report on stroke. According to news reporting from the University [...]

A recent trial called ESPRIT found that intensive blood pressure-lowering treatment to a target of less than 120 mm Hg reduced cardiovascular events in high-risk individuals compared to standard treatment with a target of less than 140 mm Hg. The trial included patients with diabetes and those with a history of stroke, two groups that were excluded in a previous trial. The results suggest that intensive blood pressure lowering is beneficial for these groups as well. Implementing this treatment strategy has the potential to save lives and reduce the burden of heart disease worldwide. [Extracted from the article]

A recent study called ARTESIA found that patients with subclinical atrial fibrillation (AFib) detected by implanted devices had a lower risk of stroke or systemic embolism when treated with the oral anticoagulant apixaban compared to aspirin. However, there was a higher risk of major bleeding with apixaban. Another study called NOAH-AFNET 6 failed to show a reduction in stroke with the anticoagulant edoxaban versus placebo in a similar patient group. The lead investigators of both trials believe that the studies show consistent results, with a lower rate of stroke than expected in this population. The question remains whether the reduction in stroke with anticoagulation outweighs the increase in major bleeding. [Extracted from the article]

The article discusses the link between periodontitis and neurologic diseases, focusing on the increased risks of stroke and Alzheimer's disease. Topics include the epidemiologic association between periodontitis and neurologic diseases, the biological mechanisms explaining the link, and the potential of periodontal treatment as a preventive measure.

The article provides a list of acute-care hospitals in Tucson, Arizona, ranking them based on the number of patients admitted in 2022. The top hospitals include TMC Health, Northwest Medical Center, Oro Valley Hospital, and Southern Arizona VA Health Care System. Each hospital offers a range of specialties and services, catering to different healthcare needs in the community. The rankings are based on factual data provided by the businesses themselves, and the information is presented in a straightforward and informative manner for readers conducting research on healthcare facilities in Tucson. [Extracted from the article]

A study presented at the American Academy of Otolaryngology–Head and Neck Surgery 2024 Annual Meeting introduced a modified sleep apnea severity index (mSASI) that combines various factors to assess obstructive sleep apnea (OSA) severity more comprehensively than the standard apnea-hypopnea index (AHI). The study found that patients with higher mSASI scores were more likely to have cardiovascular risk factors and hypertension. The research suggests that the AHI may not be the most effective tool for evaluating overall OSA severity and cardiovascular risk, highlighting the need for further population-level data and prospective studies in this area. [Extracted from the article]